Japan Demands China Release Soon Detained Employee of Drugmaker
The Astellas Pharma Inc. headquarters in Tokyo, Japan, on Friday, Aug. 19, 2022. Astellas Pharma is planning to seek regulatory review in Europe for an experimental drug that reduces the severity of hot flashes in menopausal women, according to Yasukawa. Photographer: Akio Kon/Bloomberg